THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

JANUS HENDERSON GROUP PLC's Holding History (CIK: 0001274173)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 400,496 Value ($000) $7,493 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 127,208 Value ($000) $1,857 Avg Close $12.64 Range $10.82 - $14.87
Q4 2024
Shares 24,666 Value ($000) $232 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 24,666 Value ($000) $199 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 24,666 Value ($000) $209 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 24,903 Value ($000) $223 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 24,897 Value ($000) $280 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 24,937 Value ($000) $215 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 24,988 Value ($000) $259 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 25,043 Value ($000) $272 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 10,988 Value ($000) $123 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 10,989 Value ($000) $112 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 11,074 Value ($000) $100 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 10,996 Value ($000) $105 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 10,999 Value ($000) $122 Avg Close $8.72 Range $7.30 - $11.24